Tag: Lens Therapeutics
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia for up to 10 hours, a condition impacting approximately 128 million adults in the United States